Prevalence of systemic sclerosis in south-east Norway

Rheumatology (United Kingdom)

Volumn 51, Issue 9, 2012, Pages 1600-1605

  Hoffmann Vold, Anna Maria ^a,b   Midtvedt, Øyvind ^a   Molberg, Øyvind ^a,b   Garen, Torhild ^a   Gran, Jan Tore ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoimmune diseases; Connective tissue diseases; Epidemiology; Prevalence; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; DIFFUSE SCLERODERMA; FEMALE; HEALTH SURVEY; HUMAN; LIMITED SCLERODERMA; LOCALIZED SCLERODERMA; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SYSTEMIC SCLEROSIS;

ADULT; AGE OF ONSET; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; NUCLEAR PROTEINS; PREVALENCE; REGISTRIES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED;

EID: 84865344843     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes076     Document Type: Article

References (30)

1. Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911-6.
2. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
3. Hesselstrand R, Scheja A, Åkesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
4. Steen V, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-4.
5. Radstake TR, Gorlova O, Rueda B et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2011;42:426-9.
6. Masi AT, Rodnan GP, Medsger TA Jr et al. Subcommittee for scleroderma criteria of American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
7. Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allerg Immunol 2011;40: 78-83.
8. Poormoghim H, Lucas M, Fertig N et al. Systemic sclerosis sine scleroderma: demographic, clinical, and serological features, and survival in forty-eight patients. Arthritis Rheum 2000;43:444-51.
9. Scussel-Lonzetti L, Joyal F, Raynauld JP et al. Predicting mortality in systemic sclerosis: analyses of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002; 81:154-67.
10. LeRøy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
11. Medsger TA Jr, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971;74:714-21.
12. Chifflot H, Fautrel B, Sordet C et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223-35.
13. Steen VD, Oddis CV, Conte CG et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-5.
14. Mayes MD, Lacey JV Jr, Beebe-Dimmer J. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
15. Englert H, Small-McMahon J, Davis K et al. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 1999;32:998-1006.
16. Roberts-Thomson PJ, Jones M, Hakendorf P. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Int Med J 2001;31:220-9.
17. Englert H, Joyner J, Bade R. Systemic scleroderma: a spatiotemporal clustering. Int Med J 2005;35:228-33.
18. Silman AJ, Howard Y, Hicklin AJ, Black C. Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990;29:93-6.
19. Valesini G, Litta A, Bonavita MS. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 1993;11:41-7.
20. Arnett FC, Howard RF, Tan F. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-70.
21. Le Guern V, Mahr A, Mouthon L et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004;43:1129-37.
22. Allcock RJ, Forrest I, Corris PA et al. A study of the prevalence of the systemic sclerosis in northeast England. Rheumatology 2004;43:596-602.
23. Arias-Nunez MC, Llorca J, Vazquez-Rodriguez T et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 2008;87:272-80.
24. Radic M, Martinovic Kaliterna D, Fabijanic D et al. Prevalence of systemic sclerosis in Spli-Dalmatia County in southern Croatia. Clin Rheumatol 2010;29:419-21.
25. Johnson SR, Feldman BM, Hawker GA. Classification criteria for systemic sclerosis subsets. J Rheumatol 2007; 34:1855-63.
26. Mayes MD. Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 1997;9:557-61.
27. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991;283:366-71.
28. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiologic study. Ann Rheum Dis 1994;53:502-5.
29. Alamanos Y, Tsifetaki N, Voulgari PV et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 2005;34:714-20.
30. Meune C, Avouac J, Airò P et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011;63:2790-6.